{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:06:36Z","timestamp":1794805596265,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Narcolepsy Type 1 (NT1) is a neurological sleep disorder, characterized by the loss of hypocretin\/orexin signaling in the brain. Genetic, epidemiological and experimental data support the hypothesis that NT1 is a T-cell-mediated autoimmune disease targeting the hypocretin producing neurons. While autoreactive CD4<jats:sup>+<\/jats:sup>\u2009T cells have been detected in patients, CD8<jats:sup>+<\/jats:sup>\u2009T cells have only been examined to a minor extent. Here we detect CD8<jats:sup>+<\/jats:sup>\u2009T cells specific toward narcolepsy-relevant peptides presented primarily by NT1-associated HLA types in the blood of 20 patients with NT1 as well as in 52 healthy controls, using peptide-MHC-I multimers labeled with DNA barcodes. In healthy controls carrying the\u00a0disease-predisposing HLA-DQB1*06:02 allele, the frequency of autoreactive CD8<jats:sup>+<\/jats:sup>\u2009T cells was lower as compared with both NT1 patients and HLA-DQB1*06:02-negative healthy individuals. These findings suggest that a certain level of CD8<jats:sup>+<\/jats:sup>\u2009T-cell reactivity combined with HLA-DQB1*06:02 expression is important for NT1 development.<\/jats:p>","DOI":"10.1038\/s41467-019-08774-1","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T11:04:24Z","timestamp":1550574264000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens"],"prefix":"10.1038","volume":"10","author":[{"given":"Natasja Wulff","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaj Pagh","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1831-6746","authenticated-orcid":false,"given":"Anne-Mette","family":"Bjerregaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalie Kai","family":"Bentzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Marion","family":"Marquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tripti","family":"Tamhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer S\u00f8lvsten","family":"Burgdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Ullum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul","family":"Jennum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5937-4344","authenticated-orcid":false,"given":"Sine Reker","family":"Hadrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte Rahbek","family":"Kornum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"8774_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","volume":"369","author":"Y Dauvilliers","year":"1980","unstructured":"Dauvilliers, Y., Arnulf, I. & Mignot, E. Narcolepsy with cataplexy. Lancet 369, 499\u2013511 (1980).","journal-title":"Lancet"},{"key":"8774_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.sleep.2010.05.010","volume":"12","author":"S Overeem","year":"2011","unstructured":"Overeem, S. et al. The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Sleep. Med. 12, 12\u201318 (2011).","journal-title":"Sleep. Med."},{"key":"8774_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.smrv.2007.08.010","volume":"12","author":"G Plazzi","year":"2008","unstructured":"Plazzi, G., Serra, L. & Ferri, R. Nocturnal aspects of narcolepsy with cataplexy. Sleep Med. Rev. 12, 109\u2013128 (2008).","journal-title":"Sleep Med. Rev."},{"key":"8774_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","volume":"355","author":"S Nishino","year":"2000","unstructured":"Nishino, S., Ripley, B., Overeem, S., Lammers, G. J. & Mignot, E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355, 39\u201340 (2000).","journal-title":"Lancet"},{"key":"8774_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","volume":"27","author":"TC Thannickal","year":"2000","unstructured":"Thannickal, T. C. et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469\u2013474 (2000).","journal-title":"Neuron"},{"key":"8774_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1750-3639.2003.tb00033.x","volume":"13","author":"TC Thannickal","year":"2003","unstructured":"Thannickal, T. C., Siegel, J. M., Nienhuis, R. & Moore, R. Y. Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol. 13, 340\u2013351 (2003).","journal-title":"Brain Pathol."},{"key":"8774_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1086\/318799","volume":"68","author":"E Mignot","year":"2001","unstructured":"Mignot, E. et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am. J. Hum. Genet. 68, 686\u2013699 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"8774_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1749-6632.1988.tb27056.x","volume":"540","author":"T Juji","year":"1988","unstructured":"Juji, T., Matsuki, K., Tokunaga, K., Naohara, T. & Honda, Y. Narcolepsy and HLA in the Japanese. Ann. N. Y. Acad. Sci. 540, 106\u2013114 (1988).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"8774_CR9","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.5665\/sleep.4066","volume":"37","author":"F Han","year":"2014","unstructured":"Han, F. et al. HLA DQB1*06:02 negative narcolepsy with hypocretin\/orexin deficiency. Sleep 37, 1601\u20131608 (2014).","journal-title":"Sleep"},{"key":"8774_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.5665\/sleep.5532","volume":"39","author":"M Tafti","year":"2016","unstructured":"Tafti, M. et al. Narcolepsy-associated HLA class I alleles implicate cell-mediated cytotoxicity. Sleep 39, 581\u2013587 (2016).","journal-title":"Sleep"},{"key":"8774_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ajhg.2014.12.010","volume":"96","author":"HM Ollila","year":"2015","unstructured":"Ollila, H. M. et al. HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am. J. Hum. Genet. 96, 136\u2013146 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"8774_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0033723","volume":"7","author":"M Partinen","year":"2012","unstructured":"Partinen, M. et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS ONE 7, 1\u20139 (2012).","journal-title":"PLoS ONE"},{"key":"8774_CR13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/ana.22587","volume":"70","author":"F Han","year":"2011","unstructured":"Han, F. et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china. Ann. Neurol. 70, 410\u2013417 (2011).","journal-title":"Ann. Neurol."},{"key":"8774_CR14","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1093\/brain\/awt187","volume":"136","author":"Y Dauvilliers","year":"2013","unstructured":"Dauvilliers, Y. et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain 136, 2486\u20132496 (2013).","journal-title":"Brain"},{"key":"8774_CR15","first-page":"1","volume":"3","author":"BR Kornum","year":"2017","unstructured":"Kornum, B. R. et al. Narcolepsy. Nat. Rev. Dis. Prim. 3, 1\u201319 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"8774_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","volume":"562","author":"D Latorre","year":"2018","unstructured":"Latorre, D. et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562, 63\u201368 (2018).","journal-title":"Nature"},{"key":"8774_CR17","doi-asserted-by":"publisher","first-page":"12323","DOI":"10.1073\/pnas.1818150116","volume":"115","author":"G Luo","year":"2018","unstructured":"Luo, G. et al. Autoimmunity to hypocretin and molecular mimicry to flu antigens in type 1 narcolepsy. PNAS 115, 12323\u201312332 (2018).","journal-title":"PNAS"},{"key":"8774_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0014-4886(90)90054-V","volume":"110","author":"SD Styren","year":"1990","unstructured":"Styren, S. D., Civin, W. H. & Rogers, J. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer\u2019s disease brain. Exp. Neurol. 110, 93\u2013104 (1990).","journal-title":"Exp. Neurol."},{"key":"8774_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/nyas.12793","volume":"1351","author":"M Degn","year":"2015","unstructured":"Degn, M. & Kornum, B. R. Type 1 narcolepsy: a CD8 + T cell-mediated disease? Ann. N. Y. Acad. Sci. 1351, 80\u201388 (2015).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"8774_CR20","first-page":"1305","volume":"70","author":"Y Dauvilliers","year":"2013","unstructured":"Dauvilliers, Y. et al. Hypothalamic immunopathology in anti-ma-associated diencephalitis with narcolepsy-cataplexy. JAMA Neurol. 70, 1305\u20131310 (2013).","journal-title":"JAMA Neurol."},{"key":"8774_CR21","doi-asserted-by":"publisher","first-page":"10956","DOI":"10.1073\/pnas.1603325113","volume":"113","author":"R Bernard-Valnet","year":"2016","unstructured":"Bernard-Valnet, R. et al. CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc. Natl. Acad. Sci. 113, 10956\u201310961 (2016).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"8774_CR22","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/nbt.3662","volume":"34","author":"AK Bentzen","year":"2016","unstructured":"Bentzen, A. K. et al. Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat. Biotechnol. 34, 1037\u20131045 (2016).","journal-title":"Nat. Biotechnol."},{"key":"8774_CR23","doi-asserted-by":"crossref","unstructured":"International classification of sleep disorders. In:American Academy of Sleep Medicine. 146, 1387\u20131394 (2014).","DOI":"10.1378\/chest.14-0970"},{"key":"8774_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1172\/JCI41366","volume":"120","author":"V Cvetkovic-lopes","year":"2010","unstructured":"Cvetkovic-lopes, V. et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J. Clin. Invest. 120, 713\u2013719 (2010).","journal-title":"J. Clin. Invest."},{"key":"8774_CR25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1101\/gad.207654.112","volume":"27","author":"J Dalal","year":"2013","unstructured":"Dalal, J. et al. Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation. Genes Dev. 27, 565\u2013578 (2013).","journal-title":"Genes Dev."},{"key":"8774_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0004254","volume":"4","author":"M Honda","year":"2009","unstructured":"Honda, M. et al. IGFBP3 colocalizes with and regulates hypocretin (orexin). PLoS ONE 4, 1\u201314 (2009).","journal-title":"PLoS ONE"},{"key":"8774_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nn.4462","volume":"20","author":"RA Romanov","year":"2017","unstructured":"Romanov, R. A. et al. Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes. Nat. Neurosci. 20, 176\u2013188 (2017).","journal-title":"Nat. Neurosci."},{"key":"8774_CR28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1242\/dev.117424","volume":"142","author":"J Liu","year":"2015","unstructured":"Liu, J. et al. Evolutionarily conserved regulation of hypocretin neuron specification by Lhx9. Development 142, 1113\u20131124 (2015).","journal-title":"Development"},{"key":"8774_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1126\/scitranslmed.aad2353","volume":"7","author":"A Vassalli","year":"2015","unstructured":"Vassalli, A., Li, S. & Tafti, M. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci. Transl. Med. 7, 2\u20135 (2015).","journal-title":"Sci. Transl. Med."},{"key":"8774_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"L Fagerberg","year":"2014","unstructured":"Fagerberg, L. et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell Proteom. 13, 397\u2013406 (2014).","journal-title":"Mol. Cell Proteom."},{"key":"8774_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00251-011-0579-8","volume":"64","author":"E Karosiene","year":"2012","unstructured":"Karosiene, E., Lundegaard, C., Lund, O. & Nielsen, M. NetMHCcons: a consensus method for the major histocompatibility complex class i predictions. Immunogenetics 64, 177\u2013186 (2012).","journal-title":"Immunogenetics"},{"key":"8774_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nm1360","volume":"12","author":"M Toebes","year":"2006","unstructured":"Toebes, M. et al. Design and use of conditional MHC class I ligands. Nat. Med. 12, 246\u2013251 (2006).","journal-title":"Nat. Med."},{"key":"8774_CR33","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1002\/eji.200838023","volume":"38","author":"L Berthelot","year":"2008","unstructured":"Berthelot, L. et al. Blood CD8+T-cell responses against myelin determinants in multiple sclerosis and healthy individuals. Eur. J. Immunol. 38, 1889\u20131899 (2008).","journal-title":"Eur. J. Immunol."},{"key":"8774_CR34","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1182\/blood-2003-11-4025","volume":"103","author":"MP Crawford","year":"2004","unstructured":"Crawford, M. P. et al. High prevalence of autoreactive, neuroantigen-specific CD8+T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103, 4222\u20134232 (2004).","journal-title":"Blood"},{"key":"8774_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.clim.2015.01.005","volume":"157","author":"N Sachdeva","year":"2015","unstructured":"Sachdeva, N. et al. Preproinsulin specific CD8+T cells in subjects with latent autoimmune diabetes show lower frequency and different pathophysiological characteristics than those with type 1 diabetes. Clin. Immunol. 157, 78\u201390 (2015).","journal-title":"Clin. Immunol."},{"key":"8774_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.aao4013","volume":"3","author":"S Culina","year":"2018","unstructured":"Culina, S. et al. Islet-reactive CD8+T-cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci. Immunol. 3, 1\u201315 (2018).","journal-title":"Sci. Immunol."},{"key":"8774_CR37","doi-asserted-by":"publisher","first-page":"eaar6602","DOI":"10.1126\/sciimmunol.aar6602","volume":"3","author":"MR Ehlers","year":"2018","unstructured":"Ehlers, M. R. Who let the dogs out? The ever-present threat of autoreactive T cells. Sci. Immunol. 3, eaar6602 (2018).","journal-title":"Sci. Immunol."},{"key":"8774_CR38","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1073\/pnas.0812506106","volume":"106","author":"Q Xu","year":"2009","unstructured":"Xu, Q., Schlabach, M. R., Hannon, G. J. & Elledge, S. J. Design of 240,000 orthogonal 25mer DNA barcode probes. Proc. Natl. Acad. Sci. 106, 2289\u20132294 (2009).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"8774_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nmeth.1778","volume":"9","author":"T Kivioja","year":"2012","unstructured":"Kivioja, T. et al. Counting absolute numbers of molecules using unique molecular identifiers. Nat. Methods 9, 72\u201374 (2012).","journal-title":"Nat. Methods"},{"key":"8774_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"M Robinson","year":"2010","unstructured":"Robinson, M. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).","journal-title":"Genome Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-08774-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-08774-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-08774-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T21:12:02Z","timestamp":1671225122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-08774-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["8774"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-08774-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,19]]},"assertion":[{"value":"4 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"837"}}